SKIN CLOSURE, ADHESIVE, SURGICAL

The contract specifies the procurement of 1 package of 300 adhesive surgical skin closures, identified by NSN 6510-00-054-7254, commonly known as Steri-Strips measuring 0.50 x 4 inches, sterile, with porous backing options including polypropylene film or nonwoven nylon fabric, packed in fifty envelopes per box. The product is designated as a medical device by the FDA and must comply with a 36-month shelf life requirement, with no more than five months elapsed between the manufacturer’s production date and delivery to the government. Delivery is required within five days of award, FOB destination, to FPO Zip 96672. The item must be packaged and marked in accordance with DLA Packaging Requirements (RP001), Medical Marking Standard No. 1, and MIL-STD-129 where applicable, with shipping containers suitable for common carrier transport. Hazardous material handling is governed by FED-STD-313 and TQ requirement IP025, while non-hazardous materials must meet ASTM D3951, subject to DLA technical requirements taking precedence. Technical and quality specifications are defined in the DLA Master List of Technical and Quality Requirements under RA001 and other referenced R and I codes, including RD003 for covered defense information and RS060 for shelf life classification as a Type 2 Code 7 item. The solicitation, issued under SPE2DS-26-T-088K by the Department of Defense’s Medical Supply Chain on May 20, 2026, with a response deadline of May 26, 2026, falls under NAICS code 339113 and is not a small business set-aside. It incorporates the DLA Master Solicitation for Automated Simplified Acquisitions Revision 104 and is subject to deviation 2026-00038 for multiple FAR clauses, including System for Award Management maintenance, simplified acquisition terms, and contract type. Compliance with the Berry Amendment and Buy American Act is mandatory, alongside DFARS cybersecurity requirements including NIST SP 800-171 assessments. Contractors must be registered in SAM, adhere to WAWF electronic invoicing protocols, and submit receiving reports per DFARS Appendix F. Offers must include accurate representations of small business status, excluded parties screening, and